Pular para o conteúdo principal
Ranking Invest

CYTK - Cytokinetics, Incorporated

Segmento: HealthcareCytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator that is in Phase III clinical trial in patients with heart failure; and reldesemtiv, a skeletal muscle troponin activator, which is in Phase III clinical trial to treat amyotrophic lateral sclerosis and spinal muscular atrophy. The company also develops CK-136, a novel cardiac troponin activator that is in Phase I clinical trial; aficamten, a novel cardiac myosin inhibitor, which is in Phase III clinical trial for the treatment of patients with symptomatic obstructive hypertrophic cardiomyopathy; and CK-3772271, a small molecule cardiac myosin inhibitor that is in Phase I clinical trial. Cytokinetics, Incorporated has a strategic alliance with Astellas Pharma Inc. The company was incorporated in 1997 and is headquartered in South San Francisco, California.

Análise Ranking Invest

Valor de Mercado
$ 8.52 Bi
IVR
-0.30Índice proprietário de comparação relativa: -0,30.
IVR2
-0.28Leitura proprietária complementar: -28%.
MLL
-0.28Leitura proprietária complementar: -28%.
Último Balanço Atualizado: 2T2026

O Ranking Invest utiliza metodologia proprietária baseada em dados financeiros públicos; fórmulas e valores intermediários são confidenciais.

Dados da Empresa

Patrimônio Líquido

-$ 173.49 Mi

Dívida Líquida

$ 20.29 Mi

L4T

-$ 894.00 Mi

MM4T

-4651.18%

Indicadores Básicos

ROE

515.31%

Índices de Previsibilidade

Receita Líquida

G1.80

Lucro

A0.10

Margem

D0.88

Índices de Tendência

Receita Líquida

B8.66

Lucro

G-8.08

Margem

C2.49

Índices de Endividamento

DIV/PAT

-0.12

DIV/L4T

-0.02

Dívidas
Cotação
Gráfico Lucro/Receita Líquida X TrimestrePor padrão são exibidos os últimos 16 trimestres; quando houver mais trimestres disponíveis, use o botão junto à tabela de resultados para expandir o histórico.